Our study further examined this premise and grouped the HNSCC patient cohort based on their genetic alterations of TP53 and PIK3CA. We found that the patients with both TP53 and PIK3CA gene alterations have a significantly greater hazard ratio and worse OS in 5 years. The gene discussed is TP53; the disease is head and neck squamous cell carcinoma.